The predictive model with Big ET-1 for LVRR can improve the current risk stratification of DCM, strengthen the monitoring of high-risk patients and promote more accurate screening of patients eligible for advanced therapy. The gene discussed is EDN1; the disease is familial dilated cardiomyopathy.